+1-800-267-5763
Category Archives: For Ophthalmologists
Current Concepts I, II & III Videos from the 2022 COS Annual Meeting are Now Available for Download
Aug 16th, 2022
The 2022 COS Annual Meeting & Exhibition Current Concepts I, II & III presentations are now available for download in our Members Only section. Click on the links below to view the individual talks: *presentations are in English only Current Concepts I, Friday June 10th, 2022 Racism Inside and Outside Our Walls Histopathology of Advanced […]
Physician Wellness Webinar: Reflections on the Challenges and Opportunities
Aug 11th, 2022
Physician Wellness: Reflections on the Challenges and Opportunities Date: September 12, 2022 Time: 4 p.m. PDT/5 p.m. MDT/6 p.m. CDT/7 p.m. EST / 8 p.m. ADT / 8:30 p.m. NDT Physicians and healthcare providers face complex challenges that have been amplified by the pandemic and recent global events. These challenges include ongoing workplace stressors, strain […]
Position Statement by the Canadian Ophthalmological Society (COS) Regarding Vision therapy (VT), or Behavioural Optometry
Aug 11th, 2022
August 2022 Vision therapy (VT), or behavioural optometry, is a generalized term for behavioural treatments based upon the belief that abnormalities in vision are the underlying cause of learning, neurological and spatial disabilities. A review of the available literature on these treatments conducted in 2022 by a committee of physicians specializing in pediatric ophthalmology and […]
CJO August 2022 Highlights
Aug 3rd, 2022
The August 2022 CJO is now available online. Here are some of the highlights: Resident Perspectives + visual abstract: Our amazing team of residents have summarized 7 articles with a focus on what’s most relevant to ophthalmology learners here in Canada and around the globe, including the article featured in our August visual abstract, Pretreatment […]
Virtual Retina Case Conference Canada (RCCC) 2022
Aug 3rd, 2022
The third fully virtual Retina Case Conference Canada will be held on Saturday, November 19, 2022. Last year’s meeting had the highest RCCC attendance to date with more than 80 retina colleagues logging in from across Canada!In keeping with the successful RCCC model, our live Zoom program will center around surgical and medical interactive cases […]
Canadian Ophthalmological Society (COS) Joint position paper calling for a complete ban on scleral tattooing and eyeball jewellery implantation in Manitoba
Jul 26th, 2022
September 2018 Context: There is a growing trend among body modification enthusiasts to tattoo their eyeballs (specifically the sclera of the eye) and also implant jewellery under the surface layer (conjunctiva) of the eyeball. This is being done unsafely by untrained artists under questionable conditions and leading to avariety of unfortunate complications, including loss of […]
Evidence-based clinical practice guidelines for the periodic eye examination in children aged 0-5 years in Canada
Jul 26th, 2022
December 2019 Evidence-based clinical practice guidelines for the periodic eye examination in children aged 0-5 years in Canada The Position Stated is based on current evidence and expert medical opinion available at thetime and was endorsed by the COS in November 2019. Background: As eye disease before age 5 years is common, some form of […]
Canadian Glaucoma Society Evidence-Based Recommendations for the Risk of Acute Angle Closure Glaucoma with Routine Use of Hyoscine-n-Butylbromide (Buscopan) for Gastroenterological Procedures
Jul 26th, 2022
November 2019 Evidence-Based Recommendations for the Risk of Acute Angle Closure Glaucoma with Routine Use of Hyoscine-n-Butylbromide (Buscopan) for Gastroenterological Procedures. The Position Stated is based on current evidence and expert medical opinion available at the time and was endorsed by the COS in November 2019. Background: Hyoscine-n-butylbromide (Buscopan) is a commonly used anticholinergic medication […]
Advisory Statement: Regarding Light Therapy (Photobiomodulation) for Macular Degeneration
Jul 26th, 2022
July 21, 2022 Advisory Statement: Regarding Light Therapy (Photobiomodulation) for Macular Degeneration Discussion: Patients with early dry macular degeneration often have relatively normal vision. As the disease progresses to advanced stages, patients can have both a gradual and/or sudden loss of central vision. There are no proven pharmacologic treatments for dry ARMD, however age-related eye […]